##gff-version 3
##sequence-region P51681 1 352
P51681	UniProtKB	Chain	1	352	.	.	.	ID=PRO_0000069257;Note=C-C chemokine receptor type 5	
P51681	UniProtKB	Topological domain	1	30	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	31	58	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	59	68	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	69	89	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	90	102	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	103	124	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	125	141	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	142	166	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	167	198	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	199	218	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	219	235	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	236	260	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	261	277	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	278	301	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	302	352	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Modified residue	3	3	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10089882;Dbxref=PMID:10089882	
P51681	UniProtKB	Modified residue	10	10	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21763489;Dbxref=PMID:21763489	
P51681	UniProtKB	Modified residue	14	14	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21763489;Dbxref=PMID:21763489	
P51681	UniProtKB	Modified residue	15	15	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Modified residue	337	337	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Modified residue	342	342	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Modified residue	349	349	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Lipidation	321	321	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Lipidation	323	323	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Lipidation	324	324	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Glycosylation	6	6	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Glycosylation	7	7	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:10089882;Dbxref=PMID:10089882	
P51681	UniProtKB	Glycosylation	16	16	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Glycosylation	17	17	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Disulfide bond	20	269	.	.	.	Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PDB:4MBS,ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Disulfide bond	101	178	.	.	.	Ontology_term=ECO:0000244,ECO:0000244,ECO:0000255;evidence=ECO:0000244|PDB:4MBS,ECO:0000244|PDB:5UIW,ECO:0000255|PROSITE-ProRule:PRU00521	
P51681	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_003481;Note=In INCCR5-71A%3B results in absent sulfation and greatly decreased binding CCL4 and CCL5 when associated with D-3%2C D-10 and D-15%3B restored most CCL4 binding when associated with D-3 and D-15. Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_024066;Note=I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=PMID:9399903	
P51681	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_024067;Note=C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs145061115,PMID:9399903	
P51681	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_011839;Note=A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800939,PMID:9399903	
P51681	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_003482;Note=In INCCR5-72A. R->H;Dbxref=dbSNP:rs56340326	
P51681	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_003483;Note=In TZCCR5-179. P->L	
P51681	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_024068;Note=I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1475319259,PMID:9399903	
P51681	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_011840;Note=L->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1799863,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_011841;Note=Associated with susceptibility to HIV-1%3B reduced surface expression and function of CCR5 protein. R->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11369664,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800940,PMID:11369664,PMID:9399903	
P51681	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_003484;Note=In UGCCR5-145B. K->R	
P51681	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_003485;Note=In ZWCCR5-7. Y->H;Dbxref=dbSNP:rs758090461	
P51681	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_024069;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs56198941,PMID:9399903	
P51681	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_003486;Note=In MWCCR5-107. D->N;Dbxref=dbSNP:rs149975182	
P51681	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_003487;Note=In INCCR5-467. G->E	
P51681	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_080410;Note=Rare polymorphism%3B protects against HIV-1 infection%3B CD4+ T-cells from R-106 carriers are less susceptible to infection by HIV-1 R5%3B results in reduced CCR5 surface expression. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17092330;Dbxref=dbSNP:rs183662584,PMID:17092330	
P51681	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_003488;Note=In ZWCCR5-7. L->P	
P51681	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_003489;Note=In UGCCR5-145A. F->S	
P51681	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_003490;Note=In KECCR5-116. Y->C	
P51681	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_003491;Note=In INCCR5-45C. T->A	
P51681	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_012481;Note=Rare polymorphism%3B protects against HIV-1 infection%3B CD4+ T-cells from R-178 carriers are less susceptible to infection by HIV-1 R5%3B results in reduced CCR5 surface expression. C->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10917742,ECO:0000269|PubMed:17092330;Dbxref=dbSNP:rs199824195,PMID:10917742,PMID:17092330	
P51681	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_003492;Note=In UGCCR5-145A. S->N	
P51681	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_003493;Note=In ZWCCR5-7. M->V	
P51681	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_003494;Note=In KECCR5-3B. Y->C	
P51681	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_024070;Note=S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9207783;Dbxref=dbSNP:rs1017863136,PMID:9207783	
P51681	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_011842;Note=R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800452,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_024071;Note=Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=PMID:9399903	
P51681	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_003495;Note=In INCCR5-71A. T->S	
P51681	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_003496;Note=In UGCCR5-145A. L->P;Dbxref=dbSNP:rs143181119	
P51681	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_003497;Note=In INCCR5-72A. T->M;Dbxref=dbSNP:rs534088482	
P51681	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_011843;Note=G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800943,PMID:9399903	
P51681	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_003498;Note=In TZCCR5-179. E->G	
P51681	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_003499;Note=In THCCR5-5. K->E	
P51681	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_003500;Note=In MWCCR5-1567. N->S	
P51681	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_003501;Note=In THCCR5-5. K->R	
P51681	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_003502;Note=In THCCR5-2. E->G	
P51681	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_003503;Note=In MWCCR5-1567%2C MWCCR5-1568%2C ZWCCR5-14 and ZWCCR5-112. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800944,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_003504;Note=In TZCCR5-181A and MWCCR5-107. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800945,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	345	345	.	.	.	ID=VAR_003505;Note=In UGCCR5-145C. E->G	
P51681	UniProtKB	Mutagenesis	3	3	.	.	.	Note=No sulfation and greatly decreased binding of CCL4 and CCL5%3B when associated with D-10%3B D-14 and D-15. Restored most CCL4 binding%3B when associated with D-10 and D-15. Y->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	3	3	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-10%3B F-14 and F-15. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	6	6	.	.	.	Note=No change in glycosylation status and greatly decreased CCL4 binding. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4%3B when associated with A-7%3B A-16%3B A-17. Similar molecular mass loss. Dramatically reduced binding of CCL4%3B when associated with A-7 only. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	7	7	.	.	.	Note=No change in glycosylation status and binds CCL4 as efficiently as wild type. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4%3B when associated with A-6%3B A-16%3B A-17. Similar molecular mass loss. Dramatically reduced binding of CCL4%3B when associated with A-6 only. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	10	10	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-3%3B F-14 and F-15. Small loss of sulfation%3B when associated with F-14 and F-15. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No sulfation and greatly decreased binding of CCL4 and CCL5%3B when associated with D-3%3B D-10 and D-14. No restoration of CCL4 binding%3B when associated with D-10 and D-15. Y->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-3%3B F-10%3B and F-15. Small loss of sulfation%3B when associated with F-10 and F-15. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	15	15	.	.	.	Note=No sulfation and greatly decreased binding of CCL4 and CCL5%3B when associated with D-3%3B D-10 and D-14. Restored most CCL4 binding%3B when associated with D-3 and D-10. Y->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	15	15	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-3%3B F-10 and F-14. Small loss of sulfation%3B when associated with F-10 and F-14. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Similar decrease in molecular mass when treated with O-glycosidase as for wild type%3B when associated with A-17. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Similar decrease in molecular mass when treated with O-glycosidase as for wild type%3B when associated with A-16. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Decreases to 40%25 surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Decreases to 40%25 surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Decreases to 40%25 surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Decreases to 40%25 surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Small reduction in palmitoylation. Cell surface expression reduced by 50%25. Greatly reduced palmitoylation. Cell surface expression greatly reduced%3B when associated with A-323 or A-324. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%25%3B when associated with A-323 and A-324. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Mutagenesis	323	323	.	.	.	Note=Small reduction in palmitoylation. Cell surface expression reduced by 50%25. Greatly reduced palmitoylation. Cell surface expression greatly reduced%3B when associated with A-321 or A-324. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%25%3B when associated with A-321 and A-324. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Small reduction in palmitoylation. Cell surface expression reduced by 50%25. Greatly reduced palmitoylation. Cell surface expression greatly reduced%3B when associated with A-321 or A-323. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%25%3B when associated with A-321 and A-323. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Mutagenesis	336	336	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 15%25%3B APO-RANTES-stimulated phosphorylation reduced by 30-50%25%3B when associated with A-337 or A-342 or A-349%3B APO-RANTES-stimulated phosphorylation reduced by 80%25%3B when associated with A-337 and A-342 or A-349%3B No APO-RANTES-stimulated phosphorylation%3B when associated with A-337%3B A-342 and A349%3B abolishes interaction with ARRB2%3B when associated with S-337%3B S-342 and S-349. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Mutagenesis	337	337	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 18%25%3B APO-RANTES-stimulated phosphorylation reduced by 30-50%25 on APO-RANTES stimulation%3B when associated with A-336 or A-342 or A-349%3B APO-RANTES-stimulated phosphorylation reduced by 80%25%3B when associated with A-336 and A-342 or A-349%3B No APO-RANTES-stimulated phosphorylation%3B when associated with A-336%3B A-342 and A349%3B abolishes interaction with ARRB2%3B when associated with S-336%3B S-342 and S-349. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Mutagenesis	342	342	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 42%25. Phosphorylation reduced by 50%25 on APO-RANTES stimulation%3B when associated with A-336 or A-337 or A-349%3B APO-RANTES-stimulated phosphorylation reduced by 80%25 when associated with A-336 and A-337 or A-349%3B No APO-RANTES-stimulated phosphorylation%3B when associated with A-336%3B A-337 and A349%3B abolishes interaction with ARRB2%3B when associated with S-336%3B S-337 and S-349. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Mutagenesis	349	349	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 43%25%3B APO-RANTES-stimulated phosphorylation reduced by 30-50%25%3B when associated with A-336 or A-337 or A-342%3B APO-RANTES-stimulated phosphorylation reduced by 80%25%3B when associated with A-336 and A-337 or A-342%3B No APO-RANTES-stimulated phosphorylation stimulation%3B when associated with A-336%3B A-337 and A347%3B abolishes interaction with ARRB2%3B when associated with S-336%3B S-337 and S-342. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Helix	10	13	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L87	
P51681	UniProtKB	Helix	14	17	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L87	
P51681	UniProtKB	Turn	20	22	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L87	
P51681	UniProtKB	Helix	23	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	64	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	97	131	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Turn	133	135	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	136	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	142	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Beta strand	167	172	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Beta strand	175	180	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	184	186	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	187	202	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	204	221	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	227	259	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Turn	260	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	269	288	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	289	291	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	292	299	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	302	313	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
